Canine detection and identification of SARS-CoV-2

The research article “Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat” focuses on the use of detection dogs to identify SARS-CoV-2 infection through armpit sweat odor. The study collected sweat samples from positive and negative human patients, confirmed by qPCR tests, across multiple hospitals and organizations in Belgium. These samples were then used to train six dogs under controlled conditions for 2-3 months.

The key findings from the study are:

Training and Validation: The dogs were trained using these samples, and their performance was validated over seven days. The dogs exhibited an overall sensitivity of 81%, a specificity of 98%, and an accuracy of 95%. After validation, training continued for another three months, maintaining the same level of performance​.

Context and Need for Rapid Screening: The SARS-CoV-2 pandemic highlighted the need for a fast, reliable, inexpensive, non-invasive, and widely applicable screening method to identify carriers. The limitations of existing diagnostic tests, such as qPCR, include time consumption, cost, and a high rate of false negatives, necessitating alternative methods​.

Study Objectives: The primary objectives of this study were to establish a comprehensive biobank for training detection dogs, develop a field-testing protocol, and identify the specific volatiles that make up the characteristic scent of SARS-CoV-2 positive sweat samples​.

Canine detection and identification of SARS-CoV-2 infection
  Canine detection and identification of SARS-CoV-2 infection

Detection of Vaccinated Individuals: The study also included testing sweat samples from vaccinated individuals (who received the Comirnaty vaccine). The dogs could distinguish these samples as unfavorable, indicating that vaccination did not interfere with detecting SARS-CoV-2 infection​.

Identification of Specific Volatiles: The research aimed to identify specific volatiles detected by the dogs in positive samples. The study found that SARS-CoV-2 positive samples contained distinct signature volatiles, significantly less in negative samples. This unique scent included a variety of volatiles, such as derivatives of 1-octan-3-ol, DL-3,4-dihydroxymandelic acid, urocanic acid, and octadecyl acetate​.

Public Acceptability: A survey conducted in Belgium showed high public acceptability and trust in using detection dogs for SARS-CoV-2 diagnosis. Most respondents agreed that dogs could be used for diagnosing SARS-CoV-2 infection based on sweat samples. However, there were still some doubts about the trustworthiness of this method compared to the qPCR test​.

This research demonstrates the potential of using trained dogs as a rapid, non-invasive, and effective tool for pre-screening and detecting SARS-CoV-2 infection in various settings.

 

Link to the full article: Alexander A. Aksenov scholar

Callewaert C, Pezavant M, Vandaele R, Meeus B, Vankrunkelsven E, Van Goethem P, Plumacker A, Misset B, Darcis G, Piret S, De Vleeschouwer L, Staelens F, Van Varenbergh K, Tombeur S, Ottevaere A, Montag I, Vandecandelaere P, Jonckheere S, Vandekerckhove L, Tobback E, Wieers G, Marot JC, Anseeuw K, D’Hoore L, Tuyls S, De Tavernier B, Catteeuw J, Lotfi A, Melnik A, Aksenov A, Grandjean D, Stevens M, Gasthuys F, Guyot H. Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat. Front Med (Lausanne). 2023 Sep 19;10:1185779. doi: 10.3389/fmed.2023.1185779. PMID: 37822474; PMCID: PMC10563588.

Link to the article in FrontMED

2023; 10: 1185779.
Published online 2023 Sep 19. doi: 10.3389/fmed.2023.1185779
Authors

 

  1. Chris Callewaert
    • Center for Microbial Ecology and Technology (CMET), Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium
  2. Maria Pezavant
    • Faculty of Veterinary Medicine, Clinique Vétérinaire Universitaire (CVU), University of Liège, Liège, Belgium
  3. Rony Vandaele, Bart Meeus, Ellen Vankrunkelsven, Phaedra Van Goethem
    • Federal Police Belgium, Linter, Belgium
  4. Alain Plumacker
    • CHU Saint-Pierre Hospital, Brussels, Belgium
  5. Benoit Misset
    • CHU-Sart-Tilman, Intensive Care Unit, University of Liège, Liège, Belgium
  6. Gilles Darcis
    • CHU-Sart-Tilman, Infectious Diseases – Internal Medicine, Public Health Sciences, University of Liège, Liège, Belgium
  7. Sonia Piret
    • CHU-Bruyères, Intensive Care Unit, University of Liège, Liège, Belgium
  8. Lander De Vleeschouwer
    • General Hospital (AZ) Glorieux Hospital, Ronse, Belgium
  9. Frank Staelens, Kristel Van Varenbergh, Sofie Tombeur
    • Onze Lieve Vrouwziekenhuis (OLVZ), Aalst, Belgium
  10. Anouck Ottevaere
    • General Hospital (AZ) Oudenaarde, Oudenaarde, Belgium
  11. Ilke Montag
    • Jan Yperman Hospital, Ypres, Belgium
  12. Patricia Vandecandelaere, Stijn Jonckheere
    • Laboratory of Clinical Microbiology, Jan Yperman Hospital, Ypres, Belgium
  13. Linos Vandekerckhove
    • HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium
  14. Els Tobback
    • Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital, Ghent, Belgium
  15. Gregoire Wieers
    • General Internal Medicine, Clinique Saint-Pierre Ottignies, Ottignies, Belgium
    • Namur Research Institute for Life Sciences (Narilis) and Department of Medicine, University of Namur, Namur, Belgium
  16. Jean-Christophe Marot
    • General Internal Medicine, Clinique Saint-Pierre Ottignies, Ottignies, Belgium
  17. Kurt Anseeuw
    • Department of Emergency Medicine, ZNA, Antwerp, Belgium
  18. Leen D’Hoore
    • Belgian Defence, Brussels, Belgium
    • Department of Emergency Medicine, ZNA, Antwerp, Belgium
  19. Sebastiaan Tuyls
    • Respiratory Medicine, GasthuisZusters (GZA) Hospital Group, Antwerp, Belgium
  20. Brecht De Tavernier
    • Emergency Medicine and Intensive Care, GasthuisZusters (GZA) Hospital Group, Antwerp, Belgium
  21. Julie Catteeuw
    • General Hospital (AZ) Jan Palfijn, Ghent, Belgium
  22. Ali Lotfi, Alexey Melnik, Alexander Aksenov
    • Department of Chemistry, University of Connecticut, Storrs, CT, United States
  23. Dominique Grandjean
    • Nosaïs Program, Ecole Nationale Vétérinaire d’Alfort (Alfort School of Veterinary Medicine), University Paris-Est, Maisons-Alfort, France
  24. Miguel Stevens
    • Veterinary, Ypres, Belgium
  25. Frank Gasthuys
    • Department of Surgery, Anesthesiology and Orthopedics of Large Animals, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
  26. Hugues Guyot
    • Faculty of Veterinary Medicine, Clinique Vétérinaire Universitaire (CVU), University of Liège, Liège, Belgium
Publication date 2023
Journal Frontiers in Medicine
Volume 10
Publisher Frontiers Media SA